RESUMO
Introdução: O ecocardiograma transesofágico é um exame amplamente utilizado na prática clínica para investigação e diagnóstico de doenças cardíacas e não cardíacas. Apesar de seguro, trata-se de exame semi-invasivo e não isento de ris-cos. Casos de infecção associados ao ecocardiograma tran-sesofágico foram descritos e, devido ao potencial risco de transmissão de infecção durante sua realização, o objetivo deste trabalho foi revisar dados da literatura referentes à transmissão de infecção durante a realização do exame, bem como os métodos de prevenção. Métodos: Revisão de literatura sobre o tema realizada entre dezembro de 2017 e janeiro de 2018, por meio de pesquisa em portais científicos de domínio público, nas diferentes bases de dados de ciências da saúde, que incluíram artigos originais, diretrizes, revisões simples e sistemática, e relatos de casos, publicados em periódicos indexados nos últimos 20 anos. Resultados: Preencheram os critérios estabelecidos 13 artigos: uma re-visão sistemática sobre complicações associadas ao ecocar-diograma transesofágico, seis artigos que descreveram surtos bacterianos relacionados ao ecocardiograma transesofágico, a diretriz britânica sobre limpeza e desinfecção para sondas de ecocardiografia transesofágica, quatro artigos sobre reações adversas a resíduos de ortoftaldeído em sondas de ecocardiograma transesofágico e um artigo referente ao uso de capas protetoras para as sondas. Conclusão: O risco de infecção associado ao ecocardiograma transesofágico existe, apesar de pouco descrito na literatura. É recomendado o es-tabelecimento de protocolos específicos de desinfecção das sondas de ecocardiograma transesofágico e inspeção rotinei-ra das sondas. O fortalecimento das equipes de controle de infecção também é essencial para a detecção e a resolução de surtos relacionados ao ecocardiograma transesofágico
Assuntos
Humanos , Masculino , Feminino , Desinfecção/métodos , Ecocardiografia Transesofagiana/efeitos dos fármacos , Ecocardiografia Transesofagiana/métodos , Infecções , Poluição Ambiental/prevenção & controle , Fatores de Risco , Revisão , Guias como Assunto/normas , Sonda de Prospecção , DiagnósticoRESUMO
Measurement of left ventricular stroke volume and cardiac output is very important for managing haemodynamically unstable or critically ill patients. The aims of this study were to compare stroke volume measured by three-dimensional transoesophageal echocardiography with stroke volume measured using a pulmonary artery catheter, and to examine the ability of three-dimensional transoesophageal echocardiography to track stroke volume changes induced by haemodynamic interventions. This study included 40 cardiac surgery patients. Haemodynamic variables were measured before and 2 min after haemodynamic interventions, which consisted of phenylephrine 100 µg or ephedrine 5 mg. We used Bland-Altman analysis to assess the agreement between the stroke volume measured by three-dimensional transoesophageal echocardiography and by the pulmonary artery catheter. Polar-plot and 4-quadrant plot analyses were used to assess the trending ability of three-dimensional transoesophageal echocardiography compared with the pulmonary artery catheter. Bias and percentage error were -1.2 ml and 20%, respectively. The concordance rate in the 4-quadrant analysis after phenylephrine and ephedrine administration was 75% and 84%, respectively. In the polar-plot analysis, the angular concordance rate was 66% and 73% after phenylephrine and ephedrine administration, respectively. Three-dimensional transoesophageal echocardiography was clinically acceptable for measuring stroke volume; however, it was not sufficiently reliable for tracking stroke volume changes after haemodynamic interventions.
Assuntos
Ecocardiografia Tridimensional/métodos , Ecocardiografia Transesofagiana/métodos , Monitorização Intraoperatória/métodos , Volume Sistólico/fisiologia , Idoso , Procedimentos Cirúrgicos Cardíacos , Cateterismo de Swan-Ganz/efeitos dos fármacos , Cateterismo de Swan-Ganz/métodos , Cateterismo de Swan-Ganz/estatística & dados numéricos , Ecocardiografia Tridimensional/efeitos dos fármacos , Ecocardiografia Tridimensional/estatística & dados numéricos , Ecocardiografia Transesofagiana/efeitos dos fármacos , Ecocardiografia Transesofagiana/estatística & dados numéricos , Efedrina/administração & dosagem , Feminino , Humanos , Masculino , Monitorização Intraoperatória/estatística & dados numéricos , Fenilefrina/administração & dosagem , Reprodutibilidade dos Testes , Termodiluição/métodos , Termodiluição/estatística & dados numéricosRESUMO
BACKGROUND: The hypothesis that fenoldopam mesylate, by increasing renal flow, could reduce renal damage in patients undergoing cardiac surgery with cardiopulmonary bypass has gained great interest. The aim of the current study was to quantify the relationship of the increase of the renal blood flow as a function of the fenoldopam dose in these patients and to evaluate renal flow distribution within the renal parenchyma using Doppler. METHODS: Twenty-five patients admitted to cardiac surgery have been enrolled. We used the Doppler technique to measure renal blood flow at the level of the renal, segmental, interlobar, and interlobular arteries. We calculated both the resistive and pulsatility indexes in all the renal segments. Moreover, we calculated echographically all the variables of preload, afterload, and cardiac index. Measurements were performed at baseline and after the infusion of fenoldopam mesylate at the doses of 0.05, 0.1, 0.2, and 0.3 microg x kg(-1) x min(-1). RESULTS: Fenoldopam infusion at doses more than 0.1 microg x kg(-1) x min(-1) significantly increases blood flow in all renal compartments, thus improving the resistive and pulsatility indexes starting at a dose of 0.1 microg x kg(-1) x min(-1). The highest renal flow increase is observed with 0.3 microg x kg(-1) x min(-1). Fenoldopam seems to increase the renal flow directed to the most external kidney areas. Systemic hemodynamically significant changes are observed only in patients receiving doses more than 0.1 microg x kg(-1) x min(-1). CONCLUSIONS: In hemodynamically stable patients undergoing cardiac surgery with preserved renal function, fenoldopam shows a pharmacodynamic dose-dependent profile: it significantly increases renal flow and reduces the resistances of the renal circulation starting at a dose of 0.1 microg x kg(-1) x min(-1).
Assuntos
Ponte Cardiopulmonar , Ponte de Artéria Coronária , Fenoldopam/administração & dosagem , Rim/irrigação sanguínea , Vasodilatadores/administração & dosagem , Idoso , Velocidade do Fluxo Sanguíneo/efeitos dos fármacos , Relação Dose-Resposta a Droga , Ecocardiografia Doppler em Cores/efeitos dos fármacos , Ecocardiografia Transesofagiana/efeitos dos fármacos , Feminino , Fenoldopam/efeitos adversos , Análise de Fourier , Hemodinâmica/efeitos dos fármacos , Humanos , Masculino , Pessoa de Meia-Idade , Artéria Renal/efeitos dos fármacos , Vasodilatadores/efeitos adversosAssuntos
Ponte Cardiopulmonar , Ponte de Artéria Coronária , Fenoldopam/administração & dosagem , Rim/irrigação sanguínea , Vasodilatadores/administração & dosagem , Injúria Renal Aguda/prevenção & controle , Velocidade do Fluxo Sanguíneo/efeitos dos fármacos , Relação Dose-Resposta a Droga , Ecocardiografia Doppler em Cores/efeitos dos fármacos , Ecocardiografia Transesofagiana/efeitos dos fármacos , Fenoldopam/efeitos adversos , Análise de Fourier , Hemodinâmica/efeitos dos fármacos , Humanos , Complicações Pós-Operatórias/prevenção & controle , Vasodilatadores/efeitos adversosAssuntos
Baixo Débito Cardíaco/epidemiologia , Ecocardiografia Transesofagiana , Choque Séptico/epidemiologia , Disfunção Ventricular Esquerda/epidemiologia , Baixo Débito Cardíaco/diagnóstico por imagem , Baixo Débito Cardíaco/tratamento farmacológico , Cardiotônicos/uso terapêutico , Estudos Transversais , Dobutamina/uso terapêutico , Quimioterapia Combinada , Ecocardiografia Transesofagiana/efeitos dos fármacos , Epinefrina/uso terapêutico , Hemodinâmica/efeitos dos fármacos , Mortalidade Hospitalar , Humanos , Norepinefrina/uso terapêutico , Prognóstico , Ressuscitação , Choque Séptico/diagnóstico por imagem , Choque Séptico/tratamento farmacológico , Choque Séptico/mortalidade , Volume Sistólico/efeitos dos fármacos , Taxa de Sobrevida , Disfunção Ventricular Esquerda/diagnóstico por imagem , Disfunção Ventricular Esquerda/tratamento farmacológico , Disfunção Ventricular Esquerda/mortalidadeRESUMO
RATIONALE AND OBJECTIVE: To evaluate the actual incidence of global left ventricular hypokinesia in septic shock. METHOD: All mechanically ventilated patients treated for an episode of septic shock in our unit were studied by transesophageal echocardiography, at least once a day, during the first 3 days of hemodynamic support. In patients who recovered, echocardiography was repeated after weaning from vasoactive agents. Main measurements were obtained from the software of the apparatus. Global left ventricular hypokinesia was defined as a left ventricular ejection fraction of <45%. MEASUREMENTS AND MAIN RESULTS: During a 3-yr period (January 2004 through December 2006), 67 patients free from previous cardiac disease, and who survived for >48 hrs, were repeatedly studied. Global left ventricular hypokinesia was observed in 26 of these 67 patients at admission (primary hypokinesia) and in 14 after 24 or 48 hrs of hemodynamic support by norepinephrine (secondary hypokinesia), leading to an overall hypokinesia rate of 60%. Left ventricular hypokinesia was partially corrected by dobutamine, added to a reduced dosage of norepinephrine, or by epinephrine. This reversible acute left ventricular dysfunction was not associated with a worse prognosis. CONCLUSION: Global left ventricular hypokinesia is very frequent in adult septic shock and could be unmasked, in some patients, by norepinephrine treatment. Left ventricular hypokinesia is usually corrected by addition of an inotropic agent to the hemodynamic support.
Assuntos
Baixo Débito Cardíaco/epidemiologia , Cuidados Críticos , Disfunção Ventricular Esquerda/epidemiologia , APACHE , Adulto , Idoso , Baixo Débito Cardíaco/diagnóstico por imagem , Baixo Débito Cardíaco/tratamento farmacológico , Baixo Débito Cardíaco/mortalidade , Cardiotônicos/uso terapêutico , Estudos Transversais , Dobutamina/uso terapêutico , Quimioterapia Combinada , Ecocardiografia Transesofagiana/efeitos dos fármacos , Epinefrina/uso terapêutico , Feminino , Hemodinâmica/efeitos dos fármacos , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Norepinefrina/uso terapêutico , Estudos Prospectivos , Respiração Artificial , Taxa de Sobrevida , Disfunção Ventricular Esquerda/diagnóstico por imagem , Disfunção Ventricular Esquerda/tratamento farmacológico , Disfunção Ventricular Esquerda/mortalidade , Disfunção Ventricular Direita/diagnóstico por imagem , Disfunção Ventricular Direita/tratamento farmacológico , Disfunção Ventricular Direita/epidemiologia , Disfunção Ventricular Direita/mortalidadeRESUMO
Dobutamine stress echocardiography (DSE) has been shown to be a very useful non-invasive technique for the detection of coronary artery disease. However, inadequate transthoracic images preclude the use of DSE in a significant proportion of patients. Transesophageal (TEE) or transthoracic contrast echocardiography (CE) can however overcome this limitation. The comparison between the two techniques has never been investigated during a stress test. Therefore, we designed a prospective study to compare DSE-CE and DSE-TEE for the detection of coronary artery disease in patients with poor echo image quality. We studied 42 patients scheduled for quantitative coronary angiography. Prospective DSE-CE and DSE-TEE with maximum one day interval were performed in a random order. Significant coronary artery disease was detected in 30 patients, nine with single vessel disease and 21 with multivessel disease. Sensitivity of DSE was higher with CE than with TEE (90% vs 87%, p=NS). There was no significant difference with respect to specificity in both groups (100% vs 92%, p=NS). The diagnostic accuracy was similar in both groups (93% vs 88%, NS). The kappa value for identical interpretation of a stress echocardiography study was nearly identical with both modalities 0.75 to 0.78. In poorly echogenic patients, DSE-CE is a valuable alternative for the detection of myocardial ischemia in comparison with DSE-TEE. Because DSE-CE is more comfortable than TEE, it should be used in patients with suboptimal transthoracic echocardiograms for the evaluation of coronary artery disease during DSE.
Assuntos
Doença da Artéria Coronariana/diagnóstico , Dobutamina , Ecocardiografia Transesofagiana/métodos , Idoso , Idoso de 80 Anos ou mais , Pressão Sanguínea/efeitos dos fármacos , Pressão Sanguínea/fisiologia , Doença da Artéria Coronariana/diagnóstico por imagem , Doença da Artéria Coronariana/fisiopatologia , Dobutamina/administração & dosagem , Ecocardiografia/efeitos dos fármacos , Ecocardiografia/métodos , Ecocardiografia sob Estresse/efeitos dos fármacos , Ecocardiografia sob Estresse/métodos , Ecocardiografia Transesofagiana/efeitos dos fármacos , Feminino , Frequência Cardíaca/efeitos dos fármacos , Frequência Cardíaca/fisiologia , Humanos , Masculino , Pessoa de Meia-Idade , Estudos ProspectivosRESUMO
BACKGROUND: The evaluation of chest pain or suspected coronary artery disease (CAD) in morbidly obese subjects is limited by the inability of routine diagnostic techniques to adequately image these individuals. Morbidly obese subjects are therefore often inadequately treated or inappropriately treated for presumed CAD. METHODS AND RESULTS: We prospectively evaluated 23 morbidly obese patients with chest pain using transesophageal dobutamine stress echocardiography (TE-DSE). The mean (+/- SD) weight was 164 +/- 8 kg (range, 118 to 215 kg). We identified nine patients with abnormal TE-DSE findings. Five of these patients subsequently had cardiac catheterization with confirmation of CAD in the regions identified by TE-DSE. Over a follow-up period of 18 +/- 6 months, three cardiac events (non-Q-wave myocardial infarction) occurred in the same group, including two patients without confirmatory cardiac catheterization data. Thus, seven of nine patients with positive results of TE-DSE had objective confirmatory evidence of CAD. No cardiac events were observed in the group with normal TE-DSE over the same follow-up period. CONCLUSION: TE-DSE is a safe and potentially useful technique for the evaluation of suspected CAD in morbidly obese subjects.
Assuntos
Cardiotônicos , Doença das Coronárias/diagnóstico por imagem , Dobutamina , Ecocardiografia Transesofagiana , Teste de Esforço , Isquemia Miocárdica/diagnóstico por imagem , Obesidade Mórbida/diagnóstico por imagem , Adulto , Dor no Peito/diagnóstico por imagem , Dor no Peito/etiologia , Dor no Peito/fisiopatologia , Doença das Coronárias/fisiopatologia , Diagnóstico Diferencial , Ecocardiografia Transesofagiana/efeitos dos fármacos , Teste de Esforço/efeitos dos fármacos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Infarto do Miocárdio/diagnóstico por imagem , Infarto do Miocárdio/fisiopatologia , Isquemia Miocárdica/fisiopatologia , Obesidade Mórbida/fisiopatologia , Valor Preditivo dos Testes , Estudos ProspectivosRESUMO
BACKGROUND: There is no written data about the efficacy of transesophageal electropharmacologic test (TEPT) to guide antiarrhythmic therapy in the prophylaxis of paroxysmal atrial fibrillation (PAF) recurrences. Aim of this study was to assess the efficacy of TEPT compared to empiric treatment in the prophylaxis of PAF. METHODS: One-hundred-sixty patients (pts) with previous episodes of PAF were randomized in two groups: Gr A (90 pts) was submitted to basal transesophageal electrophysiologic study (BTES); Gr B (70 pts) was submitted to randomized empiric antiarrhythmic therapy with flecainide (F), propafenone (P) and sotalol (S). The end-points of stimulation protocol in Gr A were the induction of sustained atrial fibrillation (SAF)- > or = 1 min duration- or the end of protocol. SAF was inducible in 68/90 pts (Gr A1) while it was not in 22/90 pts (Gr A2). Pts in Gr A1 were subsequently submitted to TEPT at steady-state of F, P or S randomized in first choice. Pts responders (R) (SAF non inducible) were submitted to TEPT with other antiarrhythmic drugs randomized in second choice: R were followed-up with the same drug in chronic oral assumption, while non responders (NR) were submitted to TEPT with the last drug and followed-up with the same drug both in R and NR case. The same stimulation protocol was employed in TEPT as in BTES. Pts in Gr A2 withdrew from the study. During follow-up all-pts were submitted to periodic specialist examinations every three months. In case of PAF recurrence pts withdrew from the study. RESULTS: Mean follow-up duration in the study population was 17.5 +/- 8.5 months. One-hundred-eight TEPT were performed in Gr A1: 36 tests with F, 40 with P and 32 with S. Twenty pts were R with F (55% of tests) and 17 finished the follow-up, 22 pts were R with P (55% of tests) and 16 finished the follow-up, 19 pts were R with S (59% of tests) and 15 finished the follow-up; 3 pts with F, 2 pts with P and 2 pts with S were NR in last choice and finished the follow-up. In Gr A1 61/68 pts (90%) were R and 55/68 (81%) finished the follow-up (13 pts withdrew from the study). In Gr B (70 pts) 23 pts were randomized to F and 20 finished the follow-up, 24 pts were randomized to P and 20 finished the follow-up, 23 pts were randomized to S and 20 finished the follow-up (10 pts withdrew from the study). PAF recurrences during follow-up in Gr A1 were in 15/55 pts (27%): 9/48 pts (19%) R and 6/7 pts (86%) NR, and in Gr B in 41/60 pts (68%). Gr A1 vs Gr B p < 0.001. Univariate and multivariate statistical analysis showed the empiric treatment as the only variable with high predictive value for PAF recurrences (risk ratio 1.53). PPV and NPV of TEPT were respectively 86 and 81%. CONCLUSIONS: TEPT-guided antiarrhythmic therapy in the prophylaxis of PAF recurrences seems to be an effective method in predicting the efficacy of the chronic antiarrhythmic therapy, when compared to the empiric treatment. The non inducibility of SAF at TEPT would have a high predictive value for event-free follow-up.
Assuntos
Antiarrítmicos/uso terapêutico , Fibrilação Atrial/prevenção & controle , Ecocardiografia Transesofagiana/efeitos dos fármacos , Antiarrítmicos/administração & dosagem , Feminino , Flecainida/uso terapêutico , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Propafenona/uso terapêutico , Recidiva , Sotalol/uso terapêuticoRESUMO
In 35 ASA group I and II patients we investigated the influence of haemodynamic changes induced by increasing concentrations of halothane (from 0.0 to 0.6% halothane in 70% N20) on parameters of transesophageal echocardiography (TEE). Measurements by TEE were taken in manual and automatic boundary detection mode. In manual mode the left ventricular endsystolic area (ESA) increased significantly (+16.3%) and the fractional area change (FAC) decreased significantly (-14.9%). There was no significant change of left ventricular end diastolic area (EDA). In the automatic mode there was a significant increase of ESA and EDA (+13.8%; +6.0%) and a significant decrease of FAC (-10.9%). Peak ejection rate (PER) and peak filling rate (PFR) which were also assessed in automated mode decreased significantly (-10.0%; -5.7%) under halothane. No change occurred with manually determined left ventricular endsystolic wall stress (LVEWS). The endsystolic quotient decreased significantly both in manual and automated mode during halothane (-28.3%; -29.9%). No significant difference existed between TEE measurements under apnoea versus under controlled ventilation (except for EDA in automated mode). We conclude that there is no need for apnoea conditions for TEE measurements. In conclusion, TEE proves a useful monitoring system in anesthesia which enables the investigator to assess the negative inotropic effect of halothane. Problems in its practical usage are due to the wide variation of TEE measurements.